Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Fallopian Tube Neoplasms

fluorodeoxyglucose f18 has been researched along with Fallopian Tube Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Khalil, FK; Mohamed, AZ; Tanvetyanon, T; Toloza, EM1
Andersen, G; Blaakaer, J; Bouchelouche, K; Iversen, LH; Marinovskij, E; Mikkelsen, MS; Petersen, LK; Rosenkilde, M1
Hoogendam, JP; Roze, JF; Scholten, RJ; Spijker, R; van de Wetering, FT; Veldhuis, WB; Verleye, L; Vlayen, J; Zweemer, RP1
Fukuda, H; Kaneta, T; Takahashi, S; Takanami, K; Yamada, S1
Chin, BB; Cohade, C; Patel, PV1
Futoran, R; Glaspy, J; Hawkins, R; Hoh, C; Karlan, BY; Tse, N1

Reviews

2 review(s) available for fluorodeoxyglucose f18 and Fallopian Tube Neoplasms

ArticleYear
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
    The Cochrane database of systematic reviews, 2018, Oct-08, Volume: 10

    Topics: Diffusion Magnetic Resonance Imaging; Fallopian Tube Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed

2018
Whole-body positron emission tomography with (fluorine-18)-2-deoxyglucose can detect metastatic carcinoma of the fallopian tube.
    Gynecologic oncology, 1993, Volume: 49, Issue:3

    Topics: Adenocarcinoma, Papillary; Adult; Deoxyglucose; Fallopian Tube Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed

1993

Other Studies

4 other study(ies) available for fluorodeoxyglucose f18 and Fallopian Tube Neoplasms

ArticleYear
Metastasectomy for Isolated Right-Sided Thoracic Lymph Node Metastasis From Tubal Carcinoma.
    The American surgeon, 2020, Volume: 86, Issue:5

    Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Contrast Media; Fallopian Tube Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Node Excision; Lymphatic Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Robotic Surgical Procedures; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed

2020
Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:8

    Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Cytoreduction Surgical Procedures; Diffusion Magnetic Resonance Imaging; Fallopian Tube Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2021
F-18 FDG PET/CT findings of primary carcinoma of the fallopian tube.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:6

    Topics: Fallopian Tube Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed

2009
PET-CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma.
    Gynecologic oncology, 2002, Volume: 87, Issue:3

    Topics: Aged; Fallopian Tube Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed

2002